Cinchonine
This article needs additional citations for verification. (January 2021) |
Names | |
---|---|
IUPAC name | |
Systematic IUPAC name
(S)-[(2R,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol | |
Identifiers | |
3D model (
JSmol ) |
|
89689 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.003.850 |
EC Number |
|
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H22N2O | |
Molar mass | 294.39 g/mol |
Melting point | 260-263 |
Hazards | |
GHS labelling: | |
Warning | |
H302, H317, H332 | |
P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P321, P330, P333+P313, P363, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Cinchonine is an
asymmetric synthesis in organic chemistry. It is a stereoisomer and pseudo-enantiomer of cinchonidine
.
It is structurally similar to
antimalarial
drug.
It is a
non-alcoholic fatty liver disease.[3]
References
- ^ "Common Chemistry - Substance Details - 118-10-5 : Cinchonan-9-ol, (9S)-". commonchemistry.org. Retrieved 22 May 2020.
- ISBN 978-0-85404-182-4.
- PMC 10184894.